Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Growth

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 50.42365.23-83.7020.61100.96

What is the latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE is 50.42 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202450.42
Mar2023365.23
Mar2022-83.70
Mar202120.61
Mar2020100.96

How is Core EBITDA Growth of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Growth % Change
Mar2024 50.42
-86.20
Mar2023 365.23
Positive
Mar2022 -83.7
Negative
Mar2021 20.61
-79.59
Mar2020 100.96 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Growth ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹8,170.8 Cr -1.4% 12.2% -6.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,284.0 Cr -0% -0.4% 10.2% Stock Analytics
DIVIS LABORATORIES ₹183,268.0 Cr 1.4% 4.1% 50.3% Stock Analytics
CIPLA ₹122,253.0 Cr 0.5% 1.6% 1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹113,988.0 Cr -1.2% 7.1% 18.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,921.0 Cr 1.7% 1.2% 1.5% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-1.4%

12.2%

-6.1%

SENSEX

-0.7%

3%

5%


You may also like the below Video Courses